You are here

  • Home
  • Online First
  • Evaluating residual anti-Xa levels following discontinuation of treatment-dose enoxaparin in patients presenting for elective surgery: an infographic

Article info

Article menu
Download PDFPDF
Infographic
Evaluating residual anti-Xa levels following discontinuation of treatment-dose enoxaparin in patients presenting for elective surgery: an infographic

Authors

  1. Correspondence to Dr Rajnish K Gupta, Anesthesiology, Vanderbilt University Medical Center, Nashville, TN 37232, USA; raj.gupta{at}vumc.org

Citation

Henshaw DS, Schwenk ES, Gupta RK
Evaluating residual anti-Xa levels following discontinuation of treatment-dose enoxaparin in patients presenting for elective surgery: an infographic
Regional Anesthesia & Pain Medicine Published Online First: 17 August 2023. doi: 10.1136/rapm-2023-104873

Publication history

  • Received August 1, 2023
  • Accepted August 2, 2023
  • First published August 17, 2023.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© American Society of Regional Anesthesia & Pain Medicine 2023. No commercial re-use. See rights and permissions. Published by BMJ.